Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

The 24-month follow-up of DIAGNODE-2 with the diabetes vaccine Diamyd® will be presented in early July

All 50 patients who participated in the extension of Diamyd Medical's Phase IIb trial DIAGNODE-2 with the diabetes vaccine Diamyd[®] have now made their 24-month visit, and data will be presented in early July, but without formal statistical evaluation, as the data refers to a selection of the total of 109 patients in the trial. The top-line results from 15 months were presented in September 2020. The work of starting the Phase III trial DIAGNODE-3 is in full speed with identification and contact with clinics in the USA and Europe.The primary end-point for the DIAGNODE-2 trial was read

BioStock: Sprint Bioscience’s new CEO on the business model and cancer projects

This February, Stockholm-based drug developer Sprint Bioscience announced that Erik Kinnman will take over as CEO of the company. The company specialises in preclinical development of small molecules within oncology. In an interview with BioStock, Kinnman talks more about his background, his view on the company and the business model.Read the full article at biostock.se: https://www.biostock.se/en/sprint-biosciences-new-ceo-on-the-business-model-and-cancer-projects/This is a press release from BioStock - Connecting Innovation & Capital.https://www.biostock.se

Wirtek completes acquisition and raises outlook for 2021

Company Announcement no. 06/2021 Wirtek has signed a binding contract regarding the acquisition of all the assets of two sister companies CoreBuild SRL  and Core Technology Services SRL , both located very close to Wirteks existing outsourcing facilities in Cluj-Napoca, Romania. Both sister companies – the CoreBuild companies - are profitable and growth-oriented companies working in the IT-outsourcing market just like Wirtek.The signed contract concludes the acquisition process initially announced on 18 February 2021 (company

DanCann Pharma A/S appoints Christian Carlsen as new Board Member

COPENHAGEN, Denmark, 29 April 2021 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) announced yesterday the presentation of Christian Carlsen as a new Board Member at DanCann Pharma. Christian Carlsen has a background as a professional advisor in life-science and pharma and will help provide further pace and innovation to the ambitious biopharma Company's activities.At yesterday’s general meeting of DanCann Pharma A/S, the Company's annual report was approved without remarks and there were re-elections for Carsten Trads, Per Wester, Magnus Dahlmann Østergaard and Jeppe

Grant of options

Faron Pharmaceuticals Oy (“Faron” or the “Company”) Grant of options Company announcement, 29 April 2021 at 14.45 (EEST) TURKU, FINLAND – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical-stage biopharmaceutical company, announces that the Company’s board has confirmed the grant of a total of 728,333 options over ordinary shares in the Company (“Options”) under the Company’s Share Option Plan 2019. The Options have been allocated under the Share Option Plan 2019 and are exercisable between 24 March 2022 and 24 March 2026 at an exercise price of €3.99 per

Interim report January – March 2021

Summary January – March 2021· Rental income increased 8 per cent to SEK 857 million (797). · Profit from property management increased 8 per cent to SEK 481 million (445). · Changes in value of properties amounted to SEK 589 million (110) and changes in value of financial instruments to SEK 40 million (-70). · Profit after tax for the period increased to SEK 935 million (364). · Market value of investment properties amounted to SEK 65,528 million (57,300). · During the period 17 properties (8) were acquired for SEK 1,522 million (210) and 1 property (2) was divested for SEK 7

Länsförsäkringar Bank: January – March 2021

”Länsförsäkringar Bank turns 25 this year and we are very proud of the market position that Länsförsäkringar’s banking operations have achieved during this time, with a strong local presence and modern digital services. We are celebrating our 25th anniversary by continuing our outstanding performance in the first quarter of the year. Growth in the banking business was healthy and business volumes performed well. The earnings trend was strong, largely driven by the positive performance of credit losses, but also by the strength of the underlying operations. In terms of income, net commission

Länsförsäkringar Hypotek: January – March 2021

"Länsförsäkringar Hypotek’s mortgage lending operations continued to perform positively and we can report high earnings for the period. Lending growth is stable, while credit quality remains high and credit losses very low. We are continuing to capture market shares due to the outstanding work performed locally by the regional insurance companies. At the same time, we can see continued competition in the mortgage market in which several small players, both new and established, are taking a higher share of new loans. The housing market remained strong even in the first quarter and housing

Ellevio’s Annual and Sustainability Report 2020

Ellevio AB (publ) has today published its Annual Report for 2020 on the website. The document includes Ellevio's Sustainability Report and Corporate Governance Report.The Annual Report 2020 is available in Swedish and English on Ellevio’s website under financial reports and documents: https://www.ellevio.se/en/English/about-us/financial-information/financial-reports-documents/  For further informationJesper Liveröd, Head of Media, +46 70 92 99 623, jesper.liverod@ellevio.se (jonatan.bjorck@ellevio.se)Anna-Karin Käck, SVP Finance, +46 703 44 51 57, anna-karin.kack@ellevio.se

Decisions of Atria Plc's Annual General Meeting

Atria Plc   Company Announcement, 29 April 2021 at 14.00 pmDecisions of Atria Plc's Annual General MeetingAtria Plc's Annual General Meeting was held today in Helsinki at the Atria office. In order to prevent the spread of the coronavirus pandemic, the Annual General Meeting was held without shareholders’ or their proxy representatives’ presence at the venue of the meeting. A total of 88 shareholders representing 18,478,740 shares and 101,314,569 votes were represented at the meeting. The Annual General Meeting supported all the proposals made to the Annual General Meeting by at least

Hexagon Interim Report 1 January - 31 March 2021

First quarter 2021 · Net sales increased by 10 per cent to 977.9 MEUR (889.9). Using fixed exchange rates and a comparable group structure (organic growth), net sales increased by 11 per cent · Adjusted operating earnings (EBIT1) increased by 34 per cent to 257.9 MEUR (192.4) · Earnings before taxes, excluding adjustments, amounted to 250.3 MEUR (186.6) · Net earnings, excluding adjustments, amounted to 205.2 MEUR (153.0) · Earnings per share, excluding adjustments, amounted to 0.56 EUR (0.41) · Operating cash flow increased to 211.9 MEUR (136.9) For further

Kesko Oyj - Managers' Transactions (Ritakallio, Timo)

Kesko Oyj - Managers' Transactions____________________________________________ Person subject to the notification requirementName: Ritakallio, TimoPosition: Member of the Board/Deputy memberIssuer: Kesko OyjLEI: 743700OX6HSVMCAHPB95 Notification type: INITIAL NOTIFICATIONReference number: 743700OX6HSVMCAHPB95_20210428094532_15____________________________________________ Transaction date: 2021-04-29Venue not applicableInstrument type: SHAREISIN: FI0009000202Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATION   Transaction details

Kesko Oyj - Managers' Transactions (Pokela, Toni)

Kesko Oyj - Managers' Transactions____________________________________________ Person subject to the notification requirementName: Pokela, ToniPosition: Member of the Board/Deputy memberIssuer: Kesko OyjLEI: 743700OX6HSVMCAHPB95 Notification type: INITIAL NOTIFICATIONReference number: 743700OX6HSVMCAHPB95_20210428094543_11____________________________________________ Transaction date: 2021-04-29Venue not applicableInstrument type: SHAREISIN: FI0009000202Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATION   Transaction details(1)

Kesko Oyj - Managers' Transactions (Perälä, Jussi)

Kesko Oyj - Managers' Transactions____________________________________________ Person subject to the notification requirementName: Perälä, JussiPosition: Member of the Board/Deputy memberIssuer: Kesko OyjLEI: 743700OX6HSVMCAHPB95 Notification type: INITIAL NOTIFICATIONReference number: 743700OX6HSVMCAHPB95_20210428094554_13____________________________________________ Transaction date: 2021-04-29Venue not applicableInstrument type: SHAREISIN: FI0009000202Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATION   Transaction details(

Kesko Oyj - Managers' Transactions (Karhu, Piia)

Kesko Oyj - Managers' Transactions____________________________________________ Person subject to the notification requirementName: Karhu, PiiaPosition: Member of the Board/Deputy memberIssuer: Kesko OyjLEI: 743700OX6HSVMCAHPB95 Notification type: INITIAL NOTIFICATIONReference number: 743700OX6HSVMCAHPB95_20210428094606_9____________________________________________ Transaction date: 2021-04-29Venue not applicableInstrument type: SHAREISIN: FI0009000202Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATION   Transaction details(1):

Kesko Oyj - Managers' Transactions (Fagerholm, Jannica)

Kesko Oyj - Managers' Transactions____________________________________________ Person subject to the notification requirementName: Fagerholm, JannicaPosition: Member of the Board/Deputy memberIssuer: Kesko OyjLEI: 743700OX6HSVMCAHPB95 Notification type: INITIAL NOTIFICATIONReference number: 743700OX6HSVMCAHPB95_20210428094446_3____________________________________________ Transaction date: 2021-04-29Venue not applicableInstrument type: SHAREISIN: FI0009000202Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATION   Transaction

Kesko Oyj - Managers' Transactions (Fagernäs, Peter)

Kesko Oyj - Managers' Transactions____________________________________________ Person subject to the notification requirementName: Fagernäs, PeterPosition: Member of the Board/Deputy memberIssuer: Kesko OyjLEI: 743700OX6HSVMCAHPB95 Notification type: INITIAL NOTIFICATIONReference number: 743700OX6HSVMCAHPB95_20210428094428_7____________________________________________ Transaction date: 2021-04-29Venue not applicableInstrument type: SHAREISIN: FI0009000202Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATION   Transaction details(

Kesko Oyj - Managers' Transactions (Kiiskinen, Esa)

Kesko Oyj - Managers' Transactions____________________________________________ Person subject to the notification requirementName: Kiiskinen, EsaPosition: Member of the Board/Deputy memberIssuer: Kesko OyjLEI: 743700OX6HSVMCAHPB95 Notification type: INITIAL NOTIFICATIONReference number: 743700OX6HSVMCAHPB95_20210428094406_5____________________________________________ Transaction date: 2021-04-29Venue not applicableInstrument type: SHAREISIN: FI0009000202Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATION   Transaction details(

The Nomination Committee’s proposal regarding the Annual General Meeting of MSAB

MSAB has been informed of the Nomination Committee's proposal to the Annual General Meeting on May 11[th], 2021. Item 12 – Election of Board members and auditor  The Nomination Committee, represented by Kenneth Andersen, Wilhelm Gruvberg and Henrik Tjernberg, propose that the Board of Directors shall consist of six Board members and that Jan-Olof Backman, Peter Gille, Ann Hellenius and Linda Nyberg shall be re-elected as Board members. Furthermore, Bernt Ingman and Fredrik Nilsson are nominated as new Board Members. Bernt Ingman is nominated as new Chairman of the Board. Current

Change in the holding of Kesko Corporation's treasury shares

Kesko Corporation has today transferred a total of 4,822 of its own B shares (KESKOB) held by the company as treasury shares to the members of Kesko’s Board of Directors as part of their annual fees. Kesko has also transferred 2,148 of its own B shares (KESKOB) held by the company as treasury shares to members of management and other key persons included in the target group for the 2019 and 2020 performance periods of Kesko's share-based commitment and incentive plan PSP 2019-2022.The transfer of shares to the members of the Board of Directors is based on the resolution made by Kesko’s

Change of ownership in Micro Systemation AB

Stockholm April 29[th], 2021 MSAB has today been informed about an agreement concerning change of ownership in MSAB has been concluded today. AB Grenspecialisten, Edastra AB and Cervantes Capital AB have acquired the total number of Henrik Tjernberg´s A-shares. After the completion of the transaction the major owners in MSAB will be as following: · Cervantes Capital AB: (1 544 685 number of B-shares, 127 500 number of A-shares, equivalent to 8,72% of the capital of the company and equivalent to 10,01% of the voting rights) · Edastra AB: (1 143 592 number of B-shares, 347 500

Studsvik’s Interim Report for the First Quarter 2021

· Sales in the first quarter increased in local currencies by 10 per cent and amounted to SEK 162.8 (152.9) million. · The operating profit was SEK 8.0 (3.5) million and the operating margin 4.9 (2.3) per cent. · The free cash flow was SEK 9.9 (24.1) million.Quarter Full year Q1 2021 Q1 2020 2020Sales, SEK million 162.8 152.9 721.9Operating profit, SEK million 8.0 3.5 46.0Operating margin, % 4.9 2.3 6.4Profit after tax, SEK million 2.3 –0.5 35.2

We are looking for a Customer Service and Accounting Specialist for our Operations team in Asker, Norway

Fremtiden skapes i dag. I Kiilto investerer vi i fremtiden hver dag ved å fremme yrkesmessig velvære, oppmuntre til innovasjon og gjøre driften mer og mer bærekraftig. Vi styres av ønsket om å være en miljøleder, ved å bruke vår ekspertise til å skape suksesshistorier for våre kunder. Vi er lokale, innovative og innsiktsfulle. Vil du legge til ditt eget kapittel i vår hundreårige historie om vekst?   Antibac AS ble kjøpt opp av Kiilto i mars 2019 og i dag er vårt selskap kjent som KiiltoClean AS. Basert på våre Antibac-produkter og Kiilto Pro produkter er vi Norges markedsleder innen

Interim Report January – March 2021

First quarter in brief•                    Net sales rose by 37 percent to SEK 15,723 (11,475) thousand. Organic growth was 21%. •                    Gross profit was SEK 15,017 (10,977) thousand. •                    Operating profit before depreciation and amortization (EBITDA) totaled SEK 1,958 (loss: 847) thousand. •                    Operating profit totaled SEK 551 (loss: 1,889) thousand. •                    Comprehensive income for the period totaled SEK 1,607 (loss: 1,915) thousand. •                    Comprehensive income per share, basic and diluted, totaled SEK

There are no items matching the current filter
There are no more items matching the current filter
Back to top